News
137 news
-
Drug shortages: Gustave Roussy becomes the only Cancer Centre in France authorised to produce Special Hospital Preparations
InstitutionalThe Clinical Pharmacy Department at Gustave Roussy has been authorised by the French Ministry of Health to manufacture Special Hospital Preparations (SHPs). Granted for a period of seven...
-
Personalising Breast Cancer Treatments: 5 Questions with Dr Barbara Pistilli
Clinical & Scientific AdvancesAdvances in treatment and patient care mean that five-year net survival for breast cancer now reaches 88%1 in France. However, with around 60,000 new cases diagnosed each year in France...
-
Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction
Campaigns & Community OutreachOn the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy...
-
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide
Awards & HonoursThe 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best...
-
Living with and beyond cancer: the promises and challenges of digital health
Innovation, AI & Digital HealthIn a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University...
-
Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care
Congresses, Conferences & EventsThe inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading...
-
A landmark review on myeloproliferative neoplasms published in the New England Journal of Medicine
Clinical & Scientific AdvancesResearcher Isabelle Plo and Dr William Vainchenker, a haematologist and researcher at Gustave Roussy, have co-authored a landmark review on myeloproliferative neoplasms (MPNs), published...
-
Gold September: 10 years of scientific advances for children with cancer
Paediatric OncologyThe Gold September awareness campaign, launched in France in 2016 at the initiative of Gustave Roussy, celebrates its tenth anniversary this year. Over the past decade, the campaign has...
8 results per page